To investigate the efficacy of LCM compared with placebo in reducing pain in subjects with painful distal diabetic neuropathy. Two titration schemes will be used; the first is a standard titration scheme such that the target dose of 400mg/day
To investigate the onset of action under treatment of LCM, the effect of LCM on subjects' perception of pain, sleep, activity, and quality of life, and to further investigate the safety of LCM
18 Years and older (Adult, Senior)
July 10, 2006
September 22, 2014
SCHWARZ BIOSCIENCES GmbH Monheim, Germany
† Study has passed its completion date and status has not been verified in more than two years.